Arlene Mannion - Conference.ie
Download
Report
Transcript Arlene Mannion - Conference.ie
Arlene Mannion (PhD candidate)
NUI Galway
What is Comorbidity?
Comorbidity is defined as the co-occurrence of two or
more disorders in the same person (Matson & NebelSchwalm, 2007).
A comorbid condition is a second order diagnosis
which offers core symptoms that differ from the first
disorder.
Why is it important to study
comorbidity in autism?
1. Lack of research
2. Medication
3. Priority of intervention goals
4. Long-term prognosis
5. Resources
6. Stress and burden to care providers
What are the difficulties in diagnosing
comorbid disorders in autism?
1. Overlap between ASD and intellectual disability.
2. Symptoms may vary from those seen in general
population.
3. There are considerable differences in symptoms of ASD.
4. Symptoms of comorbid disorders can change over time.
5. Lack of diagnostic instruments available to screen for
these disorders.
What is Epilepsy?
Epilepsy is a brain disorder marked by recurring
seizures or convulsions.
Epilepsy, like autism, is increasingly being described as
a spectrum disorder (Jenson, 2011).
Severity varies widely among people with epilepsy.
Difficulty of diagnosing seizures in
autism
Distinguishing seizures from non-seizures can be very
difficult in persons with autism especially where learning
disability and communication difficulties are present also.
Odd behaviours, stereotypy, aggressive behaviour,
neurological deficits, self-injurious behaviour and
diminished responsiveness may be present in a person with
autism whether they have epilepsy or not.
Seizures can often manifest in ways similar to these
features or behaviours and this can lead to confusion in
determining seizure related behaviour from non-seizures.
Symptoms of seizures
Episodes of altered consciousness or unresponsiveness that are out of the ordinary for the
person.
Not responding to tactile stimulation (touch of face or body).
Unusual eye movements (rapid eye fluttering or fixed eye deviation).
Unusual head movements.
Unusual mouth movements (chewing or lip smacking).
Unusual facial movements (twitching of face).
Stereotyped hand movements (repetitive reaching).
Unusual posturing of a limb (freezing of an arm or leg).
Unexpected incontinence.
Other less-specific symptoms:
Unexplained confusion.
Severe headaches.
Sleepiness or sleep disturbance.
Marked or unexplained irritability or aggressiveness.
Regression in normal development.
It is often very helpful for neurologists to see videotape of
events of concern as this can provide important clues.
Mannion, Leader & Healy (2013)
Participants were 89 children and adolescents with a
diagnosis of ASD.
The mean age of the sample was 9 years, ranging from 3 to
16 years. 83% (n = 74) were males and 17% (n = 15) were
female.
Prevalence of epilepsy in children/adolescents with ASD
was 10.1%.
Of those with epilepsy, the majority (66.6%) were male.
Associated factors with epilepsy in
ASD
Amiet, Gourfinkel-An, Bouzamondo, Tordjman, Baulac, Lechat,
et al. (2008) conducted a meta-analysis of epilepsy in autism.
1. Gender
Risk for epilepsy was significantly higher among females.
2. Intellectual Disability
21.4% of individuals with an intellectual disability had epilepsy .
8% of those without an intellectual disability had epilepsy.
What are sleep problems?
Insomnia
Parasomnias
Sleep related breathing disorders (e.g. Obstructive Sleep
Apnea; OSA)
Circadian rhythm sleep disorders
Why is it important to study sleep
problems in autism?
Sleep disturbance is one of the most common concerns
voiced by parents of children with autism.
Sleep affects not only children, but families.
The sleep community has identified autism as a
priority population for targeting interventions for
sleep disorders.
Why is it important to study sleep
problems in autism?
Poor sleep impacts on the individual’s health, and
daily functioning, as well as the family unit.
Sleep disorders are highly treatable.
However, evidence-based standards of care for the
surveillance, evaluation and treatment of sleep
disturbance in the ASD population are greatly needed.
Mannion, Leader & Healy (2013)
Used the Children’s Sleep Habits Questionnaire
(CSHQ) (Owens, Nobile, McGuinn & Spirito,
2000).
CSHQ is a parental report sleep screening
instrument.
It is not intended to diagnose specific sleep
disorders, but rather to identify sleep problems
and the possible need for further evaluation.
Mannion, Leader & Healy (2013)
Score of 41 is clinical cut-off for identification of probable
sleep problems.
Subscales:
Bedtime resistance
Sleep onset delay
Sleep duration
Sleep anxiety
Night wakings
Parasomnias
Sleep disordered breathing
Daytime Sleepiness.
Mannion, Leader & Healy (2013)
80.9% of children presented with a sleep problem
(Score of 41 or over on the CSHQ).
Study also examined the predictors of sleep problems.
Investigated whether age, gender, comorbid disorders
(including intellectual disability), Autism Spectrum
Disorder-Comorbid for Children (ASD-CC) score or
gastrointestinal symptoms predicted sleep problems.
Mannion, Leader & Healy (2013)
Avoidant behaviour, under-eating and total GI symptoms
predicted sleep problems.
Specifically, abdominal pain predicted sleep anxiety.
Future research needs to examine the link between sleep
problems and gastrointestinal symptoms.
Link between sleep and
gastrointestinal symptoms
Sleep disorders were found to be associated with gastrointestinal
dysfunction in children with ASD (Ming, Brimacombe, Chaaban,
Ximmerman-Bier & Wagner, 2008).
24.5% of a sample of children with ASD had both chronic
gastrointestinal symptoms and sleep problems (Williams, Christofi,
Clemmons, Rosenberg & Fuchs, 2012).
Chronic gastrointestinal symptoms were independently associated
with increased sleep dysfunction (Williams et al., 2012).
Sleep problems occurred most frequently in children with
gastrointestinal symptoms (50%) than those without (37%) (Williams,
Fuchs, Furuta, Marcon & Coury, 2010).
Link between sleep problems and
challenging behaviour
It was found that poor sleepers had a higher percentage of
behavioural problems (such as stereotypy and self injurious
behaviour) than good sleepers (Goldman, McGrew,
Johnson, Richdale, Clemons & Malow, 2011).
Medication usage, sleep problems and anxiety accounted
for 42% of the variance in challenging behaviour, with sleep
problems being the strongest predictor (Rzepecka,
McKenzie, McClure & Murphy, 2011).
Stereotypic behaviour was predicted by fewer hours of
sleep per night and screaming during the night (Schreck,
Mulick & Smith, 2004).
What are Gastrointestinal
Symptoms?
Gastrointestinal (GI) symptoms include:
Nausea
Bloating
Abdominal pain
Constipation and
Diarrhoea
Why is it important to study GI
symptoms?
They can cause pain and discomfort to individuals
with ASD.
Can have an effect on challenging behaviour.
Can interfere with learning.
Why are GI symptoms difficult to
diagnose in ASD?
1. Clinical practice guidelines exist for the diagnosis of
ASD, but do not include routine consideration of potential
gastrointestinal symptoms or other medical conditions.
2. Many individuals with ASD are non verbal and cannot
express pain or discomfort through speech.
Cannot communicate symptoms as clearly as their typically
developing peers.
Those who can verbally communicate may have difficulty
describing subjective experiences or symptoms.
Why are GI symptoms difficult to
diagnose in ASD?
3. Insistence on sameness can lead individuals to
demand stereotyped diets, that may result in
inadequate intake of fibre, fluids and other foods,
which can cause gastrointestinal symptoms.
4. If medication is administered, it can influence gut
function.
E.g. Stimulants can cause abdominal pain.
Beta blockers can cause diarrhoea, constipation and
gastric irritation (Kuddo & Nelson, 2003).
Prevalence of GI symptoms
The prevalence of gastrointestinal abnormalities in
individuals with ASD is incompletely understood.
The reported prevalence in children with ASD has
ranged from 9 to 91%.
It is an area that is in need of future research.
Mannion, Leader & Healy (2013)
Used the Gastrointestinal Symptom Inventory (Autism Treatment Network,
2005).
Measured nausea, abdominal pain, bloating, constipation and diarrhoea.
79.3% of children/adolescents had at least 1 GI symptom.
23% had 2 symptoms.
13.8% had 3 symptoms.
14.9% had 4 symptoms.
6.9% had all 5 GI symptoms.
Mannion, Leader & Healy (2013)
Of those with GI issues, most common symptoms
were:
Abdominal pain (51.7%)
Constipation (49.4%)
Diarrhoea (45.9%)
Nausea (29.9%)
Bloating (25.3%)
Mannion, Leader & Healy (2013)
79.3% of children had at least one gastrointestinal
symptom within the last 3 months.
80.9% had sleep problems.
67.8% of children had both gastrointestinal symptoms
and sleep problems.
Toileting
Toileting is a critical skill necessary for independent
living, and incontinence is a significant quality of life
barrier for individuals with autism (Kroeger &
Sorensen-Burnworth, 2009).
Dalrymple & Ruble (1992)
Dalrymple & Ruble (1992) found that lower cognition and
lower verbal levels were significantly correlated with age of
accomplishment of bowel and urine training in individuals
with autism.
About 30% of the individuals with autism had fears
associated with toileting, whereby verbal individuals had
the most.
Most common toileting problems were urinating in places
other than the toilet, constipation, stuffing up toilets,
continually flushing and smearing.
POTI
Matson, Dempsey and Fodstad (2010) developed the
Profile of Toileting Issues (POTI) questionnaire.
Lower adaptive functioning was associated with
greater toileting problems (Matson, Barker,
Shoemaker & Mahan, 2011).
Take Home Messages:
It is important to diagnose comorbid disorders in order to
provide the best possible treatment for a child with autism.
It is essential that we distinguish between the symptoms of
autism and the symptoms of comorbid disorders.
Communication impairments in autism may lead to unusual
presentations of gastrointestinal symptoms, including sleep
disturbances and challenging behaviour.
Sleep problems are highly treatable.
Take Home Messages:
We need parents to get involved in research, even if their
children are not presenting with comorbid symptoms.
By comparing children with autism with and without
comorbid symptoms, we can understand a lot more about
comorbidity.
When we understand comorbidity better, we can then focus
on establishing the most effective treatment for children with
autism.
Contact:
Arlene Mannion, PhD candidate in Irish Centre for
Autism and Neurodevelopmental Research, NUIG.
Email: [email protected]